Sumitomo Chemical India Q1 FY25 earnings call: Revenue & Margins
Q1 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹832Cr
- +25.3% QoQ
- Net profit
- ₹128Cr
- +17.4% QoQ
- Margin
- 19%
- −2 pp QoQ
Guidance rank: #20 of 25 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
Based on Sumitomo Chemical India Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1FY25 Revenue from Operations: Rs. 838.9 Cr, up 16% YoY from Rs. 724.2 Cr in Q1FY24 (Page 11). Q1FY25 EBITDA: Rs. 161.1 Cr, up 100% YoY from Rs. 80.6 Cr in Q1FY24.
From Sumitomo Chemical India Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1FY25 Revenue from Operations: Rs. 838.9 Cr, up 16% YoY from Rs. 724.2 Cr in Q1FY24 (Page 11).
- Q1FY25 Gross Profit: Rs. 326.4 Cr, 38.9% margin, 780 bps improvement YoY (Page 11).
- Q1FY25 EBITDA: Rs. 161.1 Cr, 19.2% margin, 807 bps improvement YoY (Page 11).
- Q1FY25 Net Profit: Rs. 126.7 Cr, 15.1% margin, up 105% YoY (Page 11).
2 more points from Sumitomo Chemical India Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
Q1FY25 EBITDA: Rs. 161.1 Cr, up 100% YoY from Rs. 80.6 Cr in Q1FY24
Locked: what Sumitomo Chemical India Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
- The company plans to invest approximately 15% of consolidated EBITDA annually for upgrading manufacturing facilities and capacity expansion to meet strong domestic and global demand.
- Emphasis on driving operational efficiencies while maintaining high safety standards and Responsible Care compliances during expansions.
- Continued investment in R&D for seamless integration between SCIL and SCC units to improve production processes, yields, and efficiency is planned.
- Multiple new products are in the pipeline, including global specialty proprietary products and combination/pre-mixture formulations for domestic and export markets, indicating capacity expansion aligned with these launches.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
Borrowings details from the Consolidated Balance Sheet (Page 34) show minimal current borrowings of Rs.…
Locked: what Sumitomo Chemical India Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what Sumitomo Chemical India Ltd said on order book & pipeline — free account, 30 seconds.
Sumitomo Chemical India Ltd — Quarterly revenue & net profit
Sumitomo Chemical India Ltd Q1 FY25 results — key figures
| ₹ Cr | Q1 FY25 | Q4 FY24 | QoQ |
|---|---|---|---|
| Revenue | 832 | 664 | +25.3% |
| Operating profit (EBITDA) | 162 | 139 | +16.5% |
| Operating margin | 19% | 21% | -2 pp |
| Profit before tax | 173 | 149 | +16.1% |
| Net profit (PAT) | 128 | 109 | +17.4% |
| EPS (₹) | 2.57 | 2.19 | +17.4% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹891 Cr, net profit ₹156 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sumitomo Chemical India's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Madhya Bharat Agro Products (Q1 FY25)
982 crore . Key concall takeaways from Madhya Bharat Agro Products Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
- Paradeep Phosphates (Q1 FY25)
23,774 million, down 22.2% YoY (Page 11). Key concall takeaways from Paradeep Phosphates Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
- Heranba Inds (Q1 FY25)
Q1FY25: ₹304.35 crore . Key concall takeaways from Heranba Industries Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.
- Dharmaj Crop (Q1 FY25)
Revenue from Operations for Q1FY25: ₹2,553 million, a 62% year-on-year (YoY) increase from ₹1,575 million in Q1FY24. Key concall takeaways from Dharmaj Crop…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- Madhya Bharat Agro ProductsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sumitomo Chemical India Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sumitomo Chemical India Ltd Q1 FY25 results?
Q1FY25 Revenue from Operations: Rs. 838.9 Cr, up 16% YoY from Rs. 724.2 Cr in Q1FY24 (Page 11). Q1FY25 EBITDA: Rs. 161.1 Cr, up 100% YoY from Rs. 80.6 Cr in Q1FY24.
What is Sumitomo Chemical India Ltd share price analysis?
Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 40.3 with a market cap of ₹23,003 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sumitomo Chemical India Ltd planning capital expenditure?
The company plans to invest approximately 15% of consolidated EBITDA annually for upgrading manufacturing facilities and capacity expansion to meet strong domestic and global demand.
Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
